Terms: = Kidney tumors AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2
168 results:
1. Exposure to Mycotoxin Citrinin Promotes Carcinogenic Potential of Human Renal Cells.
Tsai JF; Wu TS; Huang YT; Lin WJ; Yu FY; Liu BH
J Agric Food Chem; 2023 Dec; 71(48):19054-19065. PubMed ID: 37988173
[TBL] [Abstract] [Full Text] [Related]
2. Ipsilateral synchronous papillary renal neoplasm with reverse polarity and urothelial carcinoma in a renal transplant recipient: a rare case report with molecular analysis and literature review.
Li D; Liu F; Chen Y; Li P; Liu Y; Pang Y
Diagn Pathol; 2023 Nov; 18(1):120. PubMed ID: 37924117
[TBL] [Abstract] [Full Text] [Related]
3. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
4. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of kras signaling pathway downstream effectors.
Kim B; Lee S; Moon KC
Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
[TBL] [Abstract] [Full Text] [Related]
5. Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis.
Al Sharie AH; Abu Zahra AM; El-Elimat T; Darweesh RF; Al-Khaldi AK; Abu Mousa BM; Amer MSB; Al Zu'bi YO; Al-Kammash K; Abu Lil A; Al Malkawi AA; Alazzeh Z; Alali FQ
Medicine (Baltimore); 2023 Sep; 102(36):e35004. PubMed ID: 37682177
[TBL] [Abstract] [Full Text] [Related]
6. Pharmacokinetics of the kras
Loos NHC; Retmana IA; Rijmers J; Wang Y; Gan C; Lebre MC; Sparidans RW; Beijnen JH; Schinkel AH
Biomed Pharmacother; 2023 Oct; 166():115304. PubMed ID: 37586117
[TBL] [Abstract] [Full Text] [Related]
7. Gene mutation profiling and clinical significances in patients with renal cell carcinoma.
Wang Y; He P; Zhou X; Wang C; Fu J; Zhang D; Liao D; Zhou Z; Wu C; Gong W
Clinics (Sao Paulo); 2023; 78():100259. PubMed ID: 37515929
[TBL] [Abstract] [Full Text] [Related]
8. Non-SMC condensin I complex subunit D2 (NCAPD2) reveals its prognostic and immunologic features in human cancers.
Dong X; Liu T; Li Z; Zhai Y
Aging (Albany NY); 2023 Jul; 15(14):7237-7257. PubMed ID: 37498296
[TBL] [Abstract] [Full Text] [Related]
9. Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated Cancer.
Wang Y; Chen SY; Ta M; Senz J; Tao LV; Thornton S; Tamvada N; Yang W; Moscovitz Y; Li E; Guo J; Shen C; Douglas JM; Ei-Naggar AM; Kommoss FKF; Underhill TM; Singh N; Gilks CB; Morin GB; Huntsman DG
Cancer Res; 2023 Nov; 83(21):3517-3528. PubMed ID: 37494476
[TBL] [Abstract] [Full Text] [Related]
10. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
[TBL] [Abstract] [Full Text] [Related]
11. Primary retroperitoneal mucinous cystic neoplasm of borderline malignancy with
Son SM; Woo CG; Yun SJ; Lee OJ
J Int Med Res; 2023 May; 51(5):3000605231172469. PubMed ID: 37198972
[TBL] [Abstract] [Full Text] [Related]
12. Identification of circulating tumour DNA (ctDNA) from the liquid biopsy results: Findings from an observational cohort study.
Myint KZY; Shimabuku M; Horio R; Kaneda M; Shimizu Y; Taguchi J
Cancer Treat Res Commun; 2023; 35():100701. PubMed ID: 37094468
[TBL] [Abstract] [Full Text] [Related]
13. Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Ng KW; Boumelha J; Enfield KSS; Almagro J; Cha H; Pich O; Karasaki T; Moore DA; Salgado R; Sivakumar M; Young G; Molina-Arcas M; de Carné Trécesson S; Anastasiou P; Fendler A; Au L; Shepherd STC; Martínez-Ruiz C; Puttick C; Black JRM; Watkins TBK; Kim H; Shim S; Faulkner N; Attig J; Veeriah S; Magno N; Ward S; Frankell AM; Al Bakir M; Lim EL; Hill MS; Wilson GA; Cook DE; Birkbak NJ; Behrens A; Yousaf N; Popat S; Hackshaw A; ; ; Hiley CT; Litchfield K; McGranahan N; Jamal-Hanjani M; Larkin J; Lee SH; Turajlic S; Swanton C; Downward J; Kassiotis G
Nature; 2023 Apr; 616(7957):563-573. PubMed ID: 37046094
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in
Grenda A; Krawczyk P; Targowska-Duda KM; Kieszko R; Paśnik I; Milanowski J
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674722
[TBL] [Abstract] [Full Text] [Related]
15. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-143-3p Inhibits Wilms' Tumor Cell Growth By Targeting the Ras/Raf/MEK/ERK Pathway.
Zhang L; Shao W
Altern Ther Health Med; 2023 Mar; 29(2):140-147. PubMed ID: 36455140
[TBL] [Abstract] [Full Text] [Related]
17. Integrated Analysis of the Role of Enolase 2 in Clear Cell Renal Cell Carcinoma.
Pan J; Jin Y; Xu X; Wei W; Pan H
Dis Markers; 2022; 2022():6539203. PubMed ID: 36419844
[TBL] [Abstract] [Full Text] [Related]
18. The Possible Connection of Two Dual Function Processes: The Relationship of Ferroptosis and the JNK Pathway.
Varga D; Hajdinák P; Makk-Merczel K; Szarka A
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232313
[TBL] [Abstract] [Full Text] [Related]
19. Papillary renal cell neoplasm with reverse polarity: A new subtype of renal tumour with favorable prognosis.
Conde-Ferreirós M; Domínguez-de Dios J; Juaneda-Magdalena L; Bellas-Pereira A; San Miguel Fraile MP; Peteiro Cancelo MÁ; Gómez-de María C; Álvarez Sarria M; Betancor Santos MÁ; González-Carreró J; Ortiz-Rey JA
Actas Urol Esp (Engl Ed); 2022 Dec; 46(10):600-605. PubMed ID: 36216763
[TBL] [Abstract] [Full Text] [Related]
20. [Clinicopathological features and diagnosis of pericytic tumors of the kidney].
He YL; Zou YW; Hu YJ; Wu J; Zhang W; Yu WJ; Li YJ; Jiang YX
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):987-992. PubMed ID: 36207911
[No Abstract] [Full Text] [Related]
[Next]
